Cost-effectiveness evaluation of aspirin in primary prevention of myocardial infarction amongst males with average cardiovascular risk in Iran
Aspirin is one of the certified medicines commonly used for the secondary prevention of myocardial infarction (MI). Aspirin side effects and gastrointestinal bleeding, in particular, have arisen debates on its use for the primary prevention of MI. The present research evaluates the cost-effectivenes...
Saved in:
Main Authors: | Mohammadreza Amirsadri (Author), Mohammad Javad Sedighi (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2017-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-effectiveness and cost-utility analysis of the use of clopidogrel and pantoprazole in comparison with clopidogrel and omeprazole for the secondary prevention of myocardial infarction in Iran
by: Mohammadreza Amirsadri, et al.
Published: (2021) -
Cost-effectiveness and cost-utility analysis of type-2 diabetes screening in pharmacies in Iran
by: Mohammadreza Amirsadri, et al.
Published: (2023) -
Pharmacoeconomics in Iran: It Is Time to Take It into Practice
by: Mohammadreza Amirsadri
Published: (2015) -
Cost-Effectiveness of Alirocumab for the Secondary Prevention of Cardiovascular Events after Myocardial Infarction in the Chinese Setting
by: Zhe Liang, et al.
Published: (2021) -
Impact of Antecedent Aspirin Use on Infarct Size, Bleeding and Composite Endpoint in Patients with de Novo Acute Myocardial Infarction
by: Enhos A, et al.
Published: (2021)